0000000001034183

AUTHOR

Imke Bieber

showing 2 related works from this author

Infantile postural asymmetry and osteopathic treatment: a randomized therapeutic trial

2005

The aim of this study was to assess the therapeutic efficacy of osteopathic treatment in infants with postural asymmetry. A randomized clinical trial of efficacy with blinded videoscoring was performed. Sixty-one infants with postural asymmetry aged 6 to 12 weeks (mean 9wks) were recruited. Thirty-two infants (18 males, 14 females) with a gestational age of at least 36 weeks were found to be eligible and randomly assigned to the intervention groups, 16 receiving osteopathic treatment and 16 sham therapy. After a treatment period of 4 weeks the outcome was measured using a standardized scale (4-24 points). With sham therapy, five infants improved (at least 3 points), eight infants were uncha…

Malemedicine.medical_specialtyPediatricsPostureTreatment outcomeSham therapylaw.inventionDevelopmental NeuroscienceRandomized controlled triallawHumansMedicinebusiness.industryInfantGestational agePostural asymmetryNeuromuscular DiseasesManipulation OsteopathicTherapeutic trialTreatment periodTreatment OutcomePediatrics Perinatology and Child HealthPhysical therapyFemaleNeurology (clinical)businessDevelopmental Medicine & Child Neurology
researchProduct

Acetazolamide treatment for infantile central sleep apnea.

2001

Central sleep apnea is a common respiratory pattern in healthy neonates. Nevertheless, frequent central sleep apnea associated with drops in oxygen saturation may contribute to infantile morbidity. Recently, low-dose acetazolamide was shown to reduce symptomatic central sleep apnea in adults. We treated 12 infants, median conceptional age 42 weeks (range, 40-44 weeks), with central sleep apnea. In all cases, the central apnea index was >40/h total sleeping time (apnea ≥ 3 sec). The cumulative duration of drops in oxygen saturation below 90% was more than 3 min/h total sleeping time. All individuals received acetazolamide 7 mg/kg/day (orally, divided in three doses) for 11 weeks. Polysomn…

MaleCentral sleep apneaPolysomnographyPolysomnography030226 pharmacology & pharmacyDrug Administration ScheduleHypoxemia03 medical and health sciences0302 clinical medicineSleep Apnea SyndromesmedicineHumansOximetryRespiratory systemCarbonic Anhydrase InhibitorsOxygen saturation (medicine)medicine.diagnostic_testbusiness.industry05 social sciencesInfant Newborn050301 educationSleep apneaApneamedicine.diseaseAcetazolamideAnesthesiaPediatrics Perinatology and Child HealthFemaleNeurology (clinical)medicine.symptombusinessAcetazolamide0503 educationmedicine.drugJournal of child neurology
researchProduct